Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Orthoptic assessment of vision in patients with complex disability: the importance of understanding the patient's communication methods

Fanning C, O'Connor A.

Strabismus. 2021 Jun;29(2):125-129. doi: 10.1080/09273972.2021.1914682. Epub 2021 Apr 15.

Bacterial Extracellular Vesicles and the Gut-Microbiota Brain Axis: Emerging Roles in Communication and Potential as Therapeutics

Pirolli NH, Bentley WE, Jay SM.

Adv Biol (Weinh). 2021 Jul;5(7):e2000540. doi: 10.1002/adbi.202000540. Epub 2021 Apr 15.

Gene expression profiling of early Parkinson's disease patient reveals redox homeostasis

Zhang L, He Y, Lei K, Fang Z, Li Q, Su J, Nie Z, Xu Y, Jin L.

Neurosci Lett. 2021 May 14;753:135893. doi: 10.1016/j.neulet.2021.135893. Epub 2021 Apr 12.

Parkinson's disease and the gut: Models of an emerging relationship

Bindas AJ, Kulkarni S, Koppes RA, Koppes AN.

Acta Biomater. 2021 Sep 15;132:325-344. doi: 10.1016/j.actbio.2021.03.071. Epub 2021 Apr 20.

Impact of carbidopa-levodopa enteral suspension on quality of life and activities of daily living in patients with advanced Parkinson's disease: Results from a pooled meta-analysis

Standaert DG, Patel V, Snedecor SJ, Thakkar S, Jalundhwala YJ, Kukreja P, Kratochvil D, Bao Y, Pahwa R.

Parkinsonism Relat Disord. 2021 May;86:52-57. doi: 10.1016/j.parkreldis.2021.03.009. Epub 2021 Mar 23.

Novel N-Heteroaryl Indazole Derivatives as LRRK2 Inhibitors for Treating Parkinson's Disease

Sabnis RW.

ACS Med Chem Lett. 2021 Mar 26;12(4):530-531. doi: 10.1021/acsmedchemlett.1c00146. eCollection 2021 Apr 8.

Naturally occurring and synthetic peptides: Efficient tyrosinase inhibitors

Hariri R, Saeedi M, Akbarzadeh T.

J Pept Sci. 2021 Jul;27(7):e3329. doi: 10.1002/psc.3329. Epub 2021 Apr 15.

The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance

Menozzi E, Macnaughtan J, Schapira AHV.

Ann Med. 2021 Dec;53(1):611-625. doi: 10.1080/07853890.2021.1890330.

Fucoidan: a promising agent for brain injury and neurodegenerative disease intervention

Wang Y, Wang Q, Han X, Ma Y, Zhang Z, Zhao L, Guan F, Ma S.

Food Funct. 2021 May 11;12(9):3820-3830. doi: 10.1039/d0fo03153d.

Targeting Adenosine Receptors in Neurological Diseases

Atif M, Alsrhani A, Naz F, Imran M, Imran M, Ullah MI, Alameen AAM, Gondal TA, Raza Q.

Cell Reprogram. 2021 Apr;23(2):57-72. doi: 10.1089/cell.2020.0087.

Hypoxia and brain aging: Neurodegeneration or neuroprotection?

Burtscher J, Mallet RT, Burtscher M, Millet GP.

Ageing Res Rev. 2021 Jul;68:101343. doi: 10.1016/j.arr.2021.101343. Epub 2021 Apr 15.

Sagittal alignment changes and postoperative complications following surgery for adult spinal deformity in patients with Parkinson's disease: a multi-institutional retrospective cohort study

Kawabata A, Yoshii T, Sakai K, Hirai T, Yuasa M, Inose H, Matsukura Y, Morishita S, Tomori M, Torigoe I, Kusano K, Otani K, Arai Y, Shindo S, Okawa A.

BMC Musculoskelet Disord. 2021 Apr 16;22(1):357. doi: 10.1186/s12891-021-04233-5.

Association of small intestinal bacterial overgrowth with Parkinson's disease: a systematic review and meta-analysis

Li X, Feng X, Jiang Z, Jiang Z.

Gut Pathog. 2021 Apr 16;13(1):25. doi: 10.1186/s13099-021-00420-w.

Natural antioxidants in the management of Parkinson's disease: Review of evidence from cell line and animal models

Abdul-Latif R, Stupans I, Allahham A, Adhikari B, Thrimawithana T.

J Integr Med. 2021 Jul;19(4):300-310. doi: 10.1016/j.joim.2021.03.007. Epub 2021 Mar 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias